4//SEC Filing
AP PHARMA INC /DE/ 4
Accession 0001250320-08-000004
$HRTXCIK 0000818033operating
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 6:05 PM ET
Size
10.0 KB
Accession
0001250320-08-000004
Insider Transaction Report
Form 4
PRENTKI RONALD J
DirectorPresident & CEO
Transactions
- Purchase
Common Stock
2008-07-28$1.47/sh+5,000$7,350→ 5,000 total(indirect: By Spouse) - Purchase
Common Stock
2008-08-01$1.43/sh+660$944→ 660 total(indirect: by Mother-In-Law) - Purchase
Common Stock
2008-08-01$1.42/sh+1,200$1,704→ 1,860 total(indirect: by Mother-In-Law)
Holdings
- 1,400,000
Non-Qualified Stock Option (right to buy)
Exercise: $1.19From: 2012-07-07Exp: 2018-07-07→ Common Stock (1,400,000 underlying)
Footnotes (3)
- [F1]Open market purchase by spouse July 28, 2008
- [F2]Open market purchase by In-Law August 1, 2008
- [F3]Grant vests 25% on first anniversary of grant and 1/48 monthly thereafter.
Documents
Issuer
AP PHARMA INC /DE/
CIK 0000818033
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000818033
Filing Metadata
- Form type
- 4
- Filed
- Aug 5, 8:00 PM ET
- Accepted
- Aug 6, 6:05 PM ET
- Size
- 10.0 KB